Morgan Stanley Call 82 CVS 20.12..../ DE000MB33T03 /
28/10/2024 21:08:08 | Chg.- | Bid22:00:35 | Demandez à22:00:35 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.014EUR | - | - Bid taille: - |
- Ask la taille: - |
CVS HEALTH CORP. D... | 82.00 - | 20/12/2024 | Call |
GlobeNewswire
08/08
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
30/07
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Comme...
GlobeNewswire
11/04
Sharecare teams up with Anthem Blue Cross and Blue Shield on Jump Shot for Health initiative to supp...
GlobeNewswire
09/11/2023
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
27/09/2023
Payback Time! Community Pharmacists Cheer Class Action Lawsuit Against PBMs to Recoup DIR Fees
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page